Pentwater Capital Management LP Provention Bio, Inc. Transaction History

Pentwater Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $21 Million - $75.9 Million	3,135,000 New	3,135,000 $75.6 Million
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $67,100 - $110,399	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $101,199 - $194,500	10,000 New	10,000 $105,000
Q4 2019 Feb 14, 2020	SELL	$5.84 - $14.9 $116,800 - $298,000	-20,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.83 - $13.0 $136,600 - $260,000	20,000 New	20,000 $137,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.